Department of Anesthesia, Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, 35511, Egypt
NCT Number: NCT05455944
This study is conducted to evaluate the effects of preoperative oral pregabalin on postoperative pain and analgesic requirements in patients undergoing DCR surgery. The primary outcome is to compare pain scores by visual analogue scale (VAS). Secondary outcomes are the time of first analgesic request, the total analgesic requirements during the postoperative 24 hours, the incidence of PONV, in addition to effect on hemodynamic parameters between the two groups.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Al Mansurah, Dakahlia Governorate, 35511, Egypt
External dacryocystorhinostomy (DCR) is still considered the golden standard for lacrimal surgery. It is a bypass technique which creates an anastomosis between the lacrimal sac and the nasal mucosa through a bony ostium via an external skin incision. External DCR can be completed under either local or general anesthesia. It is a painful surgical procedure that involves intra- and extra-ocular dissection, with a high prevalence post-operative nausea and vomiting (PONV). So, it is necessary to ensure a stress-free peri-operative period with adequate pain relief and a low incidence of PONV after DCR surgery.
Pregabalin is a lipophilic gamma-amino-butyric acid (GABA) analogue that binds to the voltage-gated calcium channels. It reduces the excitability of the dorsal horn neurons after tissue damage. It has anticonvulsant, anxiolytic and sleep-modulating properties. It was shown to be effective in several models of neuropathic pain, incisional injury, and inflammatory injury.
Preoperative administration of pregabalin is supposed to be a promising technique of enhancing postoperative pain control and reduction in postoperative opioid consumption.
This study is a prospective randomized double-blind clinical trial included 100 ASA I and II patients of both sex with age between 18 and 65 years old, who are planned for elective DCR surgery under general anesthesia in Mansoura University ophthalmology center. Informed written consent is obtained from all subjects in the study after ensuring confidentiality. Details of the anesthetic technique and the study protocol are clarified to the entire involved cases. Patients are randomly assigned to two equal groups according to computer-generated randomization schedule.
A prospective analysis of the collected data is performed using the Statistical Package for the Social Sciences (SPSS) program for Windows (version 22). All data are considered statistically significant if P value is ≤ 0.05.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two capsules of pregabalin is administered orally to patients
Other names: Lyrica
Two identical placebo capsules is administered orally to patients
Other names: Control
Time frame: Up to 24 hours after the procedure
Pain (VAS) score from 0 to 10 (0 = no pain and 10 = the worst imaginable pain)
Time frame: Up to the end of the surgery
Heart rate (beat/min) is recorded at five-minute intervals until the end of the surgery
Time frame: Up to the end of the surgery
Blood pressure (mmHg) is recorded at five-minute intervals until the end of the surgery
Time frame: Up to 24 hours after the procedure
The time of the first analgesic request for pethidine is recorded.
Time frame: Up to 24 hours after the procedure
The amount of pethidine consumption given as a rescue analgesia to patients is measured all over the 24 hours.
Time frame: Up to 24 hours after the procedure
Incidence of postoperative nausea and vomiting is assessed up to 24 hours after the procedure
Sameh Fathy
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06810089
Bronchial Diseases, Bronchiolitis
Bursa, Turkey (Türkiye)
View Trial DetailsNCT00008541
Blepharitis, Conjunctival Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01772277
Dacryocystitis, Eye Diseases
Wenzhou, Zhejiang, China
View Trial DetailsNCT00349297
Dacryocystitis, Eye Diseases
Singapore
View Trial Details